タイトル無し
スポンサーリンク
概要
- 論文の詳細を見る
Because of the marked side effects associated with conticosteroid use, a switch was made to methotrexate therapy in 4 patients with cardiac sarcoidosis and the utility of this agent was investigated. As side effects induced by methotrexate, anaplastic anemia developed in one case and liver dysfunction in two. In the former case, when this agent was discontinued and G-CSF (granulocyte-colony stimulating factor) filgrastim was administered, swift improvement was attained. In the two cases with liver dysfunction, dosage reduction was required. In the remaining case, despite the absence of obvious side effects, the switch to this agent was associated with a resurgence of sarcoidosis activity, necessitating a switch back to cordicosteroid administration. Accumulation of further experience with methotrexate therapy for cardiac sarcoidosis is awaited. Our present experience was not promising in that methotrexate therapy could not be considered effective in 3 of the 4 cases.
- 日本サルコイドーシス/肉芽腫性疾患学会の論文
日本サルコイドーシス/肉芽腫性疾患学会 | 論文
- 心臓サルコイドーシスの臨床像に関する検討--データシートを用いた多施設共同研究:中間報告 (シンポジウム 心臓サルコイドーシスの新たな展開)
- 新しい心臓サルコイドーシス診断の手引きの検証 (シンポジウム 新サルコイドーシス診断基準をめぐって)
- 症例報告 ペースメーカー植込み数年後に完全房室ブロックの自然改善を認めた心臓サルコイドーシスの2症例
- 症例報告 両肺移植を施行したサルコイドーシスの1例
- 症例報告 分娩後の肺野病変増悪に対して高用量ブデソニド吸入薬を用いたサルコイドーシスの1例